Global News

Lilly closes two R&D centers, cuts 3,500 jobs

Friday, September 8, 2017

Eli Lilly announced actions to streamline operations to more efficiently focus resources on developing new medicines and to improve its cost structure. Global workforce reductions, including those from a U.S. voluntary early retirement program, are expected to impact approximately 3,500 positions.

[Read More]

VitalTrax announces availability of clinical trial network Wing

Friday, September 8, 2017

VitalTrax announced availability of Wing, a Clinical Trial Network, which gives patients, caregivers and physicians an OpenTable-like experience in finding and enrolling in clinical trials. It is a first of its kind solution that is optimized for patients’ experience. Wing contains information for over 55,000 clinical trials currently enrolling giving patients a single destination.

[Read More]

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

Friday, September 8, 2017

Two scientists at the National Cancer Institute (NCI) will receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the development of human papillomavirus (HPV) vaccines. The award is the country’s most prestigious biomedical research prize, and will be presented to John T. Schiller, Ph.D., of NCI’s Center for Cancer Research (CCR), and Douglas R. Lowy, M.D., also in CCR and acting director of NCI. NCI is part of the National Institutes of Health.

[Read More]

Forte rebrands, launches new website

Friday, September 8, 2017

Forte, a developer of clinical research solutions, announced the launch of its new brand identity and redesigned website, ForteResearch.com. The new corporate brand and website represent Forte’s vision for the future as a solutions company dedicated to helping customers unleash their full research potential by realizing their research goals and dreams.

[Read More]

Survey: Universal CRO need to have unified clinical model

Wednesday, September 6, 2017

According to a global industry survey from Veeva Systems, CROs are leading an industry-wide shift to modernize clinical systems and streamline end-to-end trial processes. The Veeva 2017 Unified Clinical Operations Survey: CRO Report reveals that CROs are making progress in moving away from manual processes and legacy systems and increasingly adopting purpose-built clinical applications. However, all CROs surveyed report the need to unify their clinical applications, including their CTMS, EDC, and eTMF, to speed study execution, reduce cost and improve study quality.

[Read More]